background purpose assess safety efficacy spot scanning proton beam radiation therapy prt treatment intracranial meningiomas patients methods sixteen patients intracranial meningioma histopathologically proven cases treated prt july NUMBER july NUMBER patients skull base lesions thirteen patients received prt surgery adjuvant therapy incomplete resection patients recurrence patients patients received radical prt presumptive diagnosis based imaging median prescribed dose NUMBER cge range cgeproton gy x NUMBER cge median NUMBER fraction gross tumor volume planning target volume ranged NUMBER NUMBER cc median NUMBER cc median NUMBER respectively late ophthalmologic toxicity assessed using subjective objective management analytic scale soma late effects normal tissue scoring national cancer institute common terminology criteria adverse events ctcae v30 grading respectively median time NUMBER months range results cumulative local control survival overall survival NUMBER NUMBER NUMBER respectively patient died recurrent meningioma patient progressed locally prt radiographic median NUMBER months revealed objective response patients stable disease NUMBER patients cumulative toxicity free survival NUMBER patient presented radiation induced optic neuropathy soma grade NUMBER retinopathy soma grade NUMBER NUMBER NUMBER months treatment respectively patients ophthalmologic toxicity received doses higher allowed structures patient developed symptomatic brain necrosis ctcae grade NUMBER NUMBER months treatment dysfunction observed conclusions prt effective treatment patient untreated recurrent incompletely resected intracranial meningiomas offers highly conformal irradiation intracranial meningiomas delivering minimal dose observed ophthalmologic toxicity NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER non ophthalmologic follow NUMBER NUMBER NUMBER year progression free follow NUMBER year radiation induced spot scanning complex shaped non target dose related NUMBER NUMBER optic ocular hypothalamic pituitary